<DOC>
	<DOC>NCT00519194</DOC>
	<brief_summary>The purpose of this study is to test the safety and efficacy of the Epicor LP Cardiac Ablation System for treating permanent atrial fibrillation during concomitant open chest and/or open heart surgery for one of more of the following procedures: mitral valve repair or replacement, aortic valve repair or replacement, tricuspid valve repair or replacement, coronary artery bypass surgery or patent foramen ovale (PFO closure).</brief_summary>
	<brief_title>CONcomitant eValuation of Epicor Left atRial Therapy for AF</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1880 years old Permanent AF defined as continuous AF lasting &gt; one year OR non selfterminating AF lasting &gt; seven days but no more than one year with at least one failed DC cardioversion Have a concomitant indication for open chest and/or open heart surgery for one or more of the following: mitral valve repair or replacement, aortic valve repair or replacement, tricuspid valve repair or replacement, patent foramen ovale (PFO) closure or coronary artery bypass surgery Be able to take anticoagulation therapy Be able to fulfill study requirements Be able to sign studyspecific informed consent Presence of a previously implanted device in or adjacent to the treatment target area that may alter the delivery of therapy Prior cardiac surgery Presence of active endocarditis, local or system infection Presence of advanced heart failure (NYHA class &gt; II, &amp; LVEF &lt; 20%) Intraaortic balloon pump, IV inotropes or vasoactive agents within 30 days Emergent cardiac surgery due to acute MI or acute mitral regurgitation Life expectancy &lt; 1 year Major or progressive noncardiac disease Presence of left atrial thrombi Left atrial diameter &gt; 6.0 cm Any condition that prevents investigator from safely performing procedure Positive urine or serum pregnancy test Prior left atrial ablation Currently participating in another clinical research study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Arrhythmia</keyword>
	<keyword>Atrial Fibrillation</keyword>
</DOC>